SR0716 103RD GENERAL ASSEMBLY

 


 
SR0716LRB103 38308 LAW 68443 r

1
SENATE RESOLUTION

 
2    WHEREAS, Feline infectious peritonitis (FIP) is a viral
3disease of cats caused by certain strains of a virus called the
4feline coronavirus; and
 
5    WHEREAS, Until recently, FIP was considered to be a
6non-treatable disease; and
 
7    WHEREAS, Once a cat develops clinical FIP, the disease is
8usually progressive and almost always fatal without the use of
9a therapy that has recently become available but has yet to be
10approved by the Food and Drug Administration (FDA) to treat
11FIP in cats; and
 
12    WHEREAS, Two drugs, GS-5734, also known as remdesivir, and
13GS-441524, a metabolite of remdesivir, showed very promising
14results, generating cure rates between 80% and 100% in both
15artificially and naturally infected cats; and
 
16    WHEREAS, Studies in both the laboratory and in
17client-owned cats with naturally occurring FIP suggest that
18GS-441524 may ultimately prove to be an effective treatment
19option for the effusive form of FIP; however, GS-441524 is
20currently not FDA-approved; and
 

 

 

SR0716- 2 -LRB103 38308 LAW 68443 r

1    WHEREAS, While a number of sources offer GS-441524 for
2sale, reports suggest that the products being provided by some
3of these sources vary widely in both accuracy of reported drug
4concentration and purity; and
 
5    WHEREAS, While remdesivir was pursued as a treatment for
6severely ill COVID-19 patients, the company that developed it
7did not seek approval for the other molecule as a veterinary
8drug, fearing that any undesirable effects discovered for that
9molecule could hinder approval of remdesivir for human use;
10therefore, be it
 
11    RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL
12ASSEMBLY OF THE STATE OF ILLINOIS, that we encourage the U.S.
13Food and Drug Administration (FDA) to approve GS-441524 and
14remdesivir to treat feline infectious peritonitis (FIP) in
15cats; and be it further
 
16    RESOLVED, That suitable copies of this resolution be
17delivered to all members of the Illinois Congressional
18Delegation and the Food and Drug Administration.